Simultaneous multiplex genome editing in yeast

Patent metadata

Field	Value
Publication number	US-11279919-B2
Application number	US-202117475392-A
Country	US
Kind code	B2
Filing date	Sep 15, 2021
Priority date	Mar 25, 2019
Publication date	Mar 22, 2022
Grant date	Mar 22, 2022

Abstract

The present disclosure provides compositions of matter, methods and instruments for editing nucleic acids in live yeast cells.

First claim

We claim:

1. A method for performing simultaneous multiplex RNA-directed nuclease editing in yeast cells using a library of linear vector backbones and a library of editing cassette constructs, comprising the steps of:
providing a library of editing cassette constructs, wherein each editing cassette construct comprises from 5′ to 3′: a pol II promoter; a transcription start site; a first editing cassette wherein the first editing cassette comprises a coding sequence for a first gRNA and a coding sequence for a first donor DNA, wherein the first donor DNA comprises a rational, desired edit to a first target sequence and an edit configured to render inactive a first proto-spacer motif (PAM) in the first target sequence; a linker; a second editing cassette wherein the second editing cassette comprises a coding sequence for a second gRNA and a coding sequence for a second donor DNA, wherein the second donor DNA comprises a rational, desired edit to a second target sequence and an edit configured to render inactive a second proto-spacer motif (PAM) in the second target sequence; a coding sequence for a self-cleaving ribozyme; and a pol II terminator; wherein the first and second editing cassettes in the library of editing cassette constructs are different among editing cassette constructs, and wherein homology exists between the library of editing cassette constructs and first and second linear vector backbones;
amplifying the library of editing cassette constructs to create an amplified library of editing cassette constructs;
providing the first linear vector backbone comprising a coding sequence for a nuclease, a coding sequence for a first antibiotic resistance gene, and a 2μ origin of replication;
providing the second linear vector backbone comprising a coding sequence for a nuclease, a coding sequence for a second antibiotic resistance gene, and a 2μ origin of replication;
transforming the yeast cells with the amplified library of editing cassette constructs and the first and second linear vector backbones where gap-repair combines the amplified library of editing cassette constructs and the first and second linear vector backbones to form editing vectors; and
providing conditions for RNA-directed nuclease editing of the yeast cells by the editing vectors.

2. The method of claim 1 , further comprising the step of providing a third linear vector backbone comprising a coding sequence for a nuclease, a coding sequence for a third antibiotic resistance gene, and a 2μ origin of replication, and wherein homology exists between the library of editing cassette constructs and the third linear vector backbones.

3. The method of claim 2 , further comprising the step of providing a fourth linear vector backbone comprising a coding sequence for a nuclease, a coding sequence for a fourth antibiotic resistance gene, and a 2μ origin of replication, and wherein homology exists between the library of editing cassette constructs and the fourth linear vector backbones.

4. The method of claim 1 , wherein the coding sequence for the nuclease in the first and second linear vector backbones is the coding sequence for the same nuclease.

5. The method of claim 1 , wherein the first antibiotic resistance gene confers resistance to hygromycin and the second antibiotic resistance gene confers resistance to G418.

6. The method of claim 1 , wherein the first and second linear vector backbones comprise the pol II promoter driving expression of the editing cassette construct.

7. The method of claim 1 , wherein each linear vector backbone further comprises an origin of replication functional in bacteria.

8. The method of claim 1 , wherein the self-cleaving ribozyme is a self-cleaving ribozyme in a hepatitis delta virus (HDV)-like ribozyme family, a self-cleaving ribozyme in a glucosamine-6-phosphate synthase ribozyme family, a self-cleaving ribozyme in a hammerhead ribozyme family, a self-cleaving ribozyme in a hairpin ribozyme family, a self-cleaving ribozyme in a Neurospora Varkud satellite ribozyme family, a self-cleaving ribozyme in a twister ribozyme family, a self-cleaving ribozyme in a twister sister ribozyme family, a self-cleaving ribozyme in a hatchet ribozyme family, or a self-cleaving ribozyme in a pistol ribozyme family.

9. The method of claim 8 , wherein the self-cleaving ribozyme is a self-cleaving ribozyme in the hepatitis delta virus (HDV)-like ribozyme family.

10. The method of claim 8 , wherein the self-cleaving ribozyme is a self-cleaving ribozyme in the glucosamine-6-phosphate synthase ribozyme family.

11. The method of claim 8 , wherein the self-cleaving ribozyme is a self-cleaving ribozyme in the Neurospora Varkud satellite ribozyme family.

12. The method of claim 8 , wherein the self-cleaving ribozyme is a self-cleaving ribozyme in the twister ribozyme family.

13. The method of claim 8 , wherein the self-cleaving ribozyme is a self-cleaving ribozyme in the twister sister ribozyme family.

14. The method of claim 8 , comprising a second self-cleaving ribozyme 3′ of the transcription start site.

15. The method of claim 8 , wherein the pol II promoter is a cell-type specific promoter, a tissue-specific promoter, or a synthetic promoter.

16. The method of claim 1 , wherein the pol II promoter is a constitutive fungal promoter.

17. The method of claim 16 , wherein the constitutive fungal pol II promoter is a pPGK1, pTDH3, pENO2, pADH1, pTPI1, pTEF1, pTEF2, pYEF3, pRPL3, pRPL15A, pRPL4, pRPL8B, pSSA1, pSSB1, pCYC or pPDA1 promoter.

18. The method of claim 17 , wherein the constitutive fungal pol II promoter is the pPGK1, pTDH3, pADH1, or pENO2 promoter.

19. The method of claim 17 , wherein the constitutive fungal pol II promoter is the pTPI1, pTEF1, pTEF2, pYEF3, pRPL3, or pRPL15A promoter.

20. The method of claim 17 , wherein the constitutive fungal pol II promoter is the pRPL4, pSSB1, pSSA1, pPDA1, or pCYC1 promoter.

21. The method of claim 1 , wherein the pol II promoter is a constitutive mammalian promoter.

22. The method of claim 21 , wherein the constitutive mammalian pol II promoter is the pCMV, pEF1a, pSV40, pPGK1, pUbc, human beta actin promoter, or pCAG promoter.

23. The method of claim 1 , wherein the pol II promoter is an inducible promoter.

24. The method of claim 23 , wherein the inducible promoter is a PHO5 promoter, a MET3 promoter, a CUP1 promoter, a GAL1 promoter, or a GEV or LEV promoter system.

25. The method of claim 1 , wherein the first gRNA in the first editing cassette is 5′ of the first donor DNA and wherein the second gRNA in the second editing cassette is 5′ of the second donor DNA.

26. The method of claim 1 , wherein the first gRNA in the first editing cassette is 3′ of the first donor DNA and wherein the second gRNA in the second editing cassette is 3′ of the second donor DNA.

27. A method for performing simultaneous multiplex RNA-directed nuclease editing in yeast cells using a library of linear vector backbones and a library of editing cassette constructs, comprising the steps of:
providing a library of editing cassette constructs, wherein each editing cassette construct comprises from 5′ to 3′: a pol II promoter; a transcription start site; a first editing cassette wherein the first editing cassette comprises a coding sequence for a first gRNA and a coding sequence for a first donor DNA, wherein the first donor DNA comprises a rational, desired edit to a first target

Assignees

• Inscripta Inc

Inventors

• Stefani Skylar
• Tian Tian
• Gander Miles

Classifications

• C12N15/102

  Mutagenizing nucleic acids · CPC title

• C12N2800/80

  Vectors containing sites for inducing double-stranded breaks, e.g. meganuclease restriction sites · CPC title

• C12N2310/20

  involving clustered regularly interspaced short palindromic repeats [CRISPR] · CPC title

• C12N15/113

  Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; {Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing (when used in plants C12N15/8218)} · CPC title

• C12N15/63

  Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression · CPC title